Anixa Biosciences (ANIX) Stock Chart & Stock Price History $2.53 -0.21 (-7.66%) (As of 05:26 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Anixa Biosciences Stock Price Performance 5 Day Performance-4.21%1 Month Performance-10.49%3 Month Performance-20.87%6 Month Performance+10.53%Year-To-Date Performance-29.64%1 Year Performance-26.61% Receive ANIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] ANIX Stock Chart for Wednesday, December, 18, 2024 ANIX Chart by TradingView Anixa Biosciences Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$2.80$2.74-2.14%$2.84$2.6747,273 shs$88.17 million12/16/2024$2.85$2.80-1.75%$2.87$2.67107,609 shs$90.10 million12/13/2024$2.93$2.85-2.73%$2.97$2.8151,348 shs$94.28 million12/12/2024$2.94$2.93-0.34%$2.99$2.8956,543 shs$94.28 million12/11/2024$2.94$2.94$2.99$2.8642,976 shs$94.61 million12/10/2024$3.00$2.94-2.00%$3.08$2.80136,177 shs$94.61 million Get the Latest News and Ratings for ANIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$3.18$3.00-5.66%$3.20$2.96121,724 shs$96.54 million12/06/2024$3.22$3.18-1.24%$3.27$3.0776,646 shs$102.33 million12/05/2024$3.24$3.22-0.62%$3.42$3.1468,393 shs$103.62 million12/04/2024$3.32$3.24-2.41%$3.43$3.24140,387 shs$104.26 million12/03/2024$3.14$3.32+5.73%$3.35$3.1476,383 shs$106.84 million12/02/2024$3.30$3.14-4.85%$3.35$3.1479,602 shs$101.04 million11/29/2024$3.31$3.30-0.30%$3.40$3.2754,504 shs$106.19 million11/28/2024$3.31$3.31$3.46$3.3066,100 shs$106.51 million11/27/2024$3.32$3.31-0.30%$3.46$3.3066,100 shs$106.52 million11/26/2024$3.22$3.32+3.11%$3.44$3.2859,742 shs$106.84 million11/25/2024$3.20$3.22+0.63%$3.39$3.18105,706 shs$103.62 million11/22/2024$3.06$3.20+4.58%$3.65$3.18627,854 shs$102.98 million11/21/2024$3.05$3.06+0.49%$3.13$3.0226,699 shs$98.47 million11/20/2024$3.12$3.05-2.40%$3.19$3.0231,056 shs$97.99 million11/19/2024$3.05$3.12+2.30%$3.26$3.0551,456 shs$100.40 million11/18/2024$3.08$3.05-0.97%$3.25$3.0588,318 shs$98.15 million Related Companies biote Stock Price Chart Design Therapeutics Stock Price Chart Voyager Therapeutics Stock Price Chart Contineum Therapeutics Stock Price Chart Acelyrin Stock Price Chart Kamada Stock Price Chart Canopy Growth Stock Price Chart Trevi Therapeutics Stock Price Chart Aquestive Therapeutics Stock Price Chart Eton Pharmaceuticals Stock Price Chart Receive ANIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANIX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anixa Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
